98 related articles for article (PubMed ID: 7809021)
1. Bombesin inhibits growth of pancreatic ductal adenocarcinoma (H2T) in nude mice.
Farre A; Ishizuka J; Gomez G; Evers BM; Saydjari R; Koo JY; Townsend CM; Thompson JC
Pancreas; 1994 Sep; 9(5):652-6. PubMed ID: 7809021
[TBL] [Abstract][Full Text] [Related]
2. Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice.
Alexander RW; Upp JR; Poston GJ; Townsend CM; Singh P; Thompson JC
Pancreas; 1988; 3(3):297-302. PubMed ID: 2838842
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide inhibits the growth of hamster pancreatic cancer but not human pancreatic cancer in vivo.
Poston GJ; Yao CZ; Upp JR; Alexander RW; Townsend CM; Thompson JC
Pancreas; 1988; 3(4):439-43. PubMed ID: 3174607
[TBL] [Abstract][Full Text] [Related]
4. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse.
Fisher WE; Muscarella P; Boros LG; Schirmer WJ
Surgery; 1998 Mar; 123(3):315-20. PubMed ID: 9526524
[TBL] [Abstract][Full Text] [Related]
5. Bombesin stimulates growth of human gastrinoma.
Chung DH; Evers BM; Beauchamp RD; Upp JR; Rajaraman S; Townsend CM; Thompson JC
Surgery; 1992 Dec; 112(6):1059-65. PubMed ID: 1455308
[TBL] [Abstract][Full Text] [Related]
6. Bombesin stimulates growth of colon cancer in mice and decreases their survival.
Farre A; Ishizuka J; Gomez G; Parekh D; Koo JY; Townsend CM; Thompson JC
Surg Oncol; 1993; 2(3):169-73. PubMed ID: 8252206
[TBL] [Abstract][Full Text] [Related]
7. Cortivazol increases glucocorticoid receptor expression and inhibits growth of hamster pancreatic cancer (H2T) in vivo.
Evers BM; Thompson EB; Townsend CM; Lawrence JL; Johnson B; Srinivasan G; Thompson JC
Pancreas; 1993 Jan; 8(1):7-14. PubMed ID: 8419910
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of pancreatic and colon cancer to cyclosporine and alpha-difluoromethylornithine in vivo.
Saydjari R; Townsend CM; Barranco SC; Thompson JC
Invest New Drugs; 1988 Dec; 6(4):265-72. PubMed ID: 3147968
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pancreatic adenocarcinoma cell growth by lovastatin.
Sumi S; Beauchamp RD; Townsend CM; Uchida T; Murakami M; Rajaraman S; Ishizuka J; Thompson JC
Gastroenterology; 1992 Sep; 103(3):982-9. PubMed ID: 1499946
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice.
Yano T; Pinski J; Szepeshazi K; Halmos G; Radulovic S; Groot K; Schally AV
Cancer; 1994 Feb; 73(4):1229-38. PubMed ID: 8313327
[TBL] [Abstract][Full Text] [Related]
13. Bombesin stimulates the in vitro growth of a human gastric cancer cell line.
Bold RJ; Lowry PS; Ishizuka J; Battey JF; Townsend CM; Thompson JC
J Cell Physiol; 1994 Dec; 161(3):519-25. PubMed ID: 7962132
[TBL] [Abstract][Full Text] [Related]
14. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
15. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Groot K; Halmos G
Int J Cancer; 1993 May; 54(2):282-9. PubMed ID: 8387464
[TBL] [Abstract][Full Text] [Related]
16. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
17. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
18. Bombesin stimulates insulin secretion by a pancreatic islet cell line.
Swope SL; Schonbrunn A
Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1822-6. PubMed ID: 6143320
[TBL] [Abstract][Full Text] [Related]
19. The effects of 2-deoxy-D-glucose and alpha-difluoromethylornithine on the growth of pancreatic cancer in vivo.
Saydjari R; Alexander RW; Barranco SC; Townsend CM; Thompson JC
Pancreas; 1989; 4(1):38-43. PubMed ID: 2497460
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
